Background Increasing evidence supports the role of the gut microbiota in the aetiology of irritable bowel syndrome (IBS). Faecal microbiota transplantation (FMT) is a highly effective treatment against recurrent Clostridioides difficile infection in randomised controlled trials (RCTs), and may be beneficial in ulcerative colitis. However, its efficacy in IBS is uncertain. Aim To perform a systematic review and meta‐analysis to examine this issue. Methods We searched MEDLINE, EMBASE, EMBASE Classic, the Cochrane Central Register of Controlled Trials, and clinicaltrials.gov through to March 2019. RCTs recruiting adults with IBS, which compared FMT with placebo, were eligible. Dichotomous symptom data were pooled to obtain a relative ris...
The intestinal microbiome has been identified as a key modifier for a variety of health conditions. ...
Background. Fecal microbiota transplantation (FMT) is an emerging treatment approach for inflammator...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not fecal microbiot...
none6siIncreasing evidence supports the role of the gut microbiota in the aetiology of irritable bow...
BACKGROUNDIrritable bowel syndrome (IBS) is the most prevalent gastrointestinal disorder in develope...
Background Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder. Although...
Summary Background Irritable bowel syndrome (IBS) has been associated with microbial dysbiosis. Aim ...
Background The intestinal microbiota is involved in the pathogenesis of inflammatory bowel disease (...
Objective: Faecal microbiota transplantation (FMT) from healthy donors to patients with irritable bo...
Background: Faecal microbiota transplantation (FMT) is emerging as a novel therapy for ulcerative co...
Abstract Background and Aims Fecal microbiota transfer (FMT) is a potential treatment for irritable ...
Background: Changes in the colonic microbiota may play a role in the pathogenesis of ulcerative coli...
Background: Clostridioides difficile infection (CDI) and inflammatory bowel disease (IBD) are globa...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not fecal microbiot...
AIM: To study the clinical efficacy and safety of Fecal microbiota transplantation (FMT). We systema...
The intestinal microbiome has been identified as a key modifier for a variety of health conditions. ...
Background. Fecal microbiota transplantation (FMT) is an emerging treatment approach for inflammator...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not fecal microbiot...
none6siIncreasing evidence supports the role of the gut microbiota in the aetiology of irritable bow...
BACKGROUNDIrritable bowel syndrome (IBS) is the most prevalent gastrointestinal disorder in develope...
Background Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder. Although...
Summary Background Irritable bowel syndrome (IBS) has been associated with microbial dysbiosis. Aim ...
Background The intestinal microbiota is involved in the pathogenesis of inflammatory bowel disease (...
Objective: Faecal microbiota transplantation (FMT) from healthy donors to patients with irritable bo...
Background: Faecal microbiota transplantation (FMT) is emerging as a novel therapy for ulcerative co...
Abstract Background and Aims Fecal microbiota transfer (FMT) is a potential treatment for irritable ...
Background: Changes in the colonic microbiota may play a role in the pathogenesis of ulcerative coli...
Background: Clostridioides difficile infection (CDI) and inflammatory bowel disease (IBD) are globa...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not fecal microbiot...
AIM: To study the clinical efficacy and safety of Fecal microbiota transplantation (FMT). We systema...
The intestinal microbiome has been identified as a key modifier for a variety of health conditions. ...
Background. Fecal microbiota transplantation (FMT) is an emerging treatment approach for inflammator...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not fecal microbiot...